AbbVie Invests $380M to Expand Illinois Manufacturing for Neuroscience, Obesity Meds
Insurance Journal - Feb 24, 2026
AbbVie on Monday said it would invest $380 million to build two new active pharmaceutical ingredient manufacturing facilities at its Illinois campus, expanding its domestic production capacity for its neuroscience and obesity medicines. The investment is part of AbbVie’s broader …...
Recommended Articles
Posted: Apr 02, 2026
Reinsurance rates continued to soften during the April 1 renewals despite the unstable geopolitical...
Posted: Apr 02, 2026
Pawtucket, Rhode Island-based toymaker Hasbro, Inc. reported it is investigating a cybersecurity inc...
Posted: Apr 02, 2026
Mississippi will soon become the latest state to provide wind-mitigation grants for homeowners if th...